Literature DB >> 34344022

Spatial transcriptomics analysis of uterine gene expression in enhancer of zeste homolog 2 conditional knockout mice†.

Ana M Mesa1,2, Jiude Mao3,4, Theresa I Medrano1, Nathan J Bivens5, Alexander Jurkevich6, Geetu Tuteja7, Paul S Cooke1, Cheryl S Rosenfeld4,8,9.   

Abstract

Histone proteins undergo various modifications that alter chromatin structure, including addition of methyl groups. Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase that methylates lysine residue 27, and thereby suppresses gene expression. EZH2 plays integral roles in the uterus and other reproductive organs. We have previously shown that conditional deletion of uterine EZH2 results in increased proliferation of luminal and glandular epithelial cells, and RNA-seq analyses reveal several uterine transcriptomic changes in Ezh2 conditional (c) knockout (KO) mice that can affect estrogen signaling pathways. To pinpoint the origin of such gene expression changes, we used the recently developed spatial transcriptomics (ST) method with the hypotheses that Ezh2cKO mice would predominantly demonstrate changes in epithelial cells and/or ablation of this gene would disrupt normal epithelial/stromal gene expression patterns. Uteri were collected from ovariectomized adult WT and Ezh2cKO mice and analyzed by ST. Asb4, Cxcl14, Dio2, and Igfbp5 were increased, Sult1d1, Mt3, and Lcn2 were reduced in Ezh2cKO uterine epithelium vs. WT epithelium. For Ezh2cKO uterine stroma, differentially expressed key hub genes included Cald1, Fbln1, Myh11, Acta2, and Tagln. Conditional loss of uterine Ezh2 also appears to shift the balance of gene expression profiles in epithelial vs. stromal tissue toward uterine epithelial cell and gland development and proliferation, consistent with uterine gland hyperplasia in these mice. Current findings provide further insight into how EZH2 may selectively affect uterine epithelial and stromal compartments. Additionally, these transcriptome data might provide mechanistic understanding and valuable biomarkers for human endometrial disorders with epigenetic underpinnings.
© The Author(s) 2021. Published by Oxford University Press on behalf of Society for the Study of Reproduction. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Female Reproduction; Histone Proteins; RNA-seq; endometrial cancer; endometrium; epigenetics; estrogen; uterus

Mesh:

Substances:

Year:  2021        PMID: 34344022      PMCID: PMC8599041          DOI: 10.1093/biolre/ioab147

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.161


  62 in total

Review 1.  Phosphorylation of epigenetic "readers, writers and erasers": Implications for developmental reprogramming and the epigenetic basis for health and disease.

Authors:  Lindsey S Treviño; Quan Wang; Cheryl L Walker
Journal:  Prog Biophys Mol Biol       Date:  2015-04-02       Impact factor: 3.667

2.  Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis.

Authors:  Silas Maniatis; Tarmo Äijö; Sanja Vickovic; Catherine Braine; Kristy Kang; Annelie Mollbrink; Delphine Fagegaltier; Žaneta Andrusivová; Sami Saarenpää; Gonzalo Saiz-Castro; Miguel Cuevas; Aaron Watters; Joakim Lundeberg; Richard Bonneau; Hemali Phatnani
Journal:  Science       Date:  2019-04-05       Impact factor: 47.728

3.  Role of thyroid dysimmunity and thyroid hormones in endometriosis.

Authors:  Marine Peyneau; Niloufar Kavian; Sandrine Chouzenoux; Carole Nicco; Mohamed Jeljeli; Laurie Toullec; Jeanne Reboul-Marty; Camille Chenevier-Gobeaux; Fernando M Reis; Pietro Santulli; Ludivine Doridot; Charles Chapron; Frédéric Batteux
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-29       Impact factor: 11.205

4.  Migration of cells from experimental endometriosis to the uterine endometrium.

Authors:  Xavier Santamaria; Efi E Massasa; Hugh S Taylor
Journal:  Endocrinology       Date:  2012-09-11       Impact factor: 4.736

5.  Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway.

Authors:  Binny V Varghese; Faezeh Koohestani; Michelle McWilliams; Arlene Colvin; Sumedha Gunewardena; William H Kinsey; Romana A Nowak; Warren B Nothnick; Vargheese M Chennathukuzhi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-02       Impact factor: 11.205

6.  The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.

Authors:  Kui-Ming Chan; Dong Fang; Haiyun Gan; Rintaro Hashizume; Chuanhe Yu; Mark Schroeder; Nalin Gupta; Sabine Mueller; C David James; Robert Jenkins; Jann Sarkaria; Zhiguo Zhang
Journal:  Genes Dev       Date:  2013-04-19       Impact factor: 11.361

Review 7.  Exploiting the therapeutic potential of the PI3K-AKT-mTOR pathway in enriched populations of gynecologic malignancies.

Authors:  Ramez N Eskander; Krishnansu S Tewari
Journal:  Expert Rev Clin Pharmacol       Date:  2014-10-10       Impact factor: 5.045

8.  Reconstructing Lineage Hierarchies of Mouse Uterus Epithelial Development Using Single-Cell Analysis.

Authors:  Bingbing Wu; Chengrui An; Yu Li; Zi Yin; Lin Gong; Zhenli Li; Yixiao Liu; Boon Chin Heng; Dandan Zhang; Hongwei Ouyang; Xiaohui Zou
Journal:  Stem Cell Reports       Date:  2017-06-15       Impact factor: 7.765

9.  Single cell RNA-seq study of wild type and Hox9,10,11 mutant developing uterus.

Authors:  Michael L Mucenski; Robert Mahoney; Mike Adam; Andrew S Potter; S Steven Potter
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

10.  The Roles of the Histone Protein Modifier EZH2 in the Uterus and Placenta.

Authors:  Ana M Mesa; Cheryl S Rosenfeld; Geetu Tuteja; Theresa I Medrano; Paul S Cooke
Journal:  Epigenomes       Date:  2020-09-02
View more
  4 in total

1.  Spatial transcriptomic profiles of mouse uterine microenvironments at pregnancy day 7.5†.

Authors:  Rong Li; Tian-Yuan Wang; Xin Xu; Olivia M Emery; MyeongJin Yi; San-Pin Wu; Francesco J DeMayo
Journal:  Biol Reprod       Date:  2022-08-09       Impact factor: 4.161

2.  EZH2 and Endometrial Cancer Development: Insights from a Mouse Model.

Authors:  Xin Fang; Nan Ni; Xiaofang Wang; Yanan Tian; Ivan Ivanov; Monique Rijnkels; Kayla J Bayless; John P Lydon; Qinglei Li
Journal:  Cells       Date:  2022-03-07       Impact factor: 7.666

3.  Integrated Analysis of Multiple Microarrays Based on Raw Data Identified Novel Gene Signatures in Recurrent Implantation Failure.

Authors:  Hong Zeng; Yu Fu; Lang Shen; Song Quan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-07       Impact factor: 5.555

4.  SWI/SNF Antagonism of PRC2 Mediates Estrogen-Induced Progesterone Receptor Expression.

Authors:  Mike R Wilson; Jake J Reske; Julie Koeman; Marie Adams; Niraj R Joshi; Asgerally T Fazleabas; Ronald L Chandler
Journal:  Cells       Date:  2022-03-15       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.